1
|
Abstract
BACKGROUND The worldwide COVID-19 pandemic caused by SARS-CoV-2 has resulted in an extraordinary increase in the number of patients who are severely critically ill. For many of these patients, cardiovascular risk factors are key contributors to the development of severe illness. Laboratory markers for cardiac damage and failure, such as natriuretic peptides, are reported to be elevated in patients with severe COVID-19. METHODS We conducted a systematic review and meta-analysis to compare natriuretic peptide levels in patients with severe COVID-19 vs those with nonsevere COVID-19. PubMed and medRxiv were searched through April 7, 2020. The outcome of interest was the difference in B-type natriuretic peptide (BNP) or N-terminal-proBNP levels in patients with severe vs nonsevere COVID-19. RESULTS We identified 9 retrospective cohort studies that had a total of 1,575 patients with COVID-19 who had their natriuretic peptides measured and were classified by disease severity. All studies were conducted in China. Patients with severe COVID-19 had significantly higher BNP levels than patients with nonsevere COVID-19 (mean difference, 69.56 pg/mL; 95% CI, 1.77-137.35 pg/mL; P = .04, I2 = 83%). Similarly, patients with severe COVID-19 had significantly higher N-terminal-proBNP levels than patients with nonsevere COVID-19 (mean difference, 518.65 pg/mL; 95% CI, 152.40-884.90 pg/mL; P = .006, I2 = 86%). CONCLUSIONS In this study, Chinese patients with severe COVID-19 had higher natriuretic peptide levels than those with nonsevere COVID-19. Studies from all countries affected by the virus will help to further delineate whether the cause is directly or indirectly of cardiac origin and whether preexisting heart failure has an influence on this disparity.
Collapse
Affiliation(s)
- Benjamin Benhuri
- Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, New York
| | - Tadao Aikawa
- Department of Cardiology, Hokkaido Cardiovascular Hospital, Sapporo, Japan
| | - Hisato Takagi
- Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan
| | - Daniel Benhuri
- Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, New York
| | - Toshiki Kuno
- Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, New York
| |
Collapse
|
2
|
Oates CP, Bienstock SW, Miller M, Giustino G, Danilov T, Kukar N, Kocovic N, Sperling D, Singh R, Benhuri D, Beerkens F, Camaj A, Lerakis S, Croft L, Stein LK, Goldman ME. Using Clinical and Echocardiographic Characteristics to Characterize the Risk of Ischemic Stroke in Patients with COVID-19. J Stroke Cerebrovasc Dis 2021; 31:106217. [PMID: 34826678 PMCID: PMC8572704 DOI: 10.1016/j.jstrokecerebrovasdis.2021.106217] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2021] [Accepted: 10/31/2021] [Indexed: 01/30/2023] Open
Abstract
Background COVID-19 has been associated with an increased incidence of ischemic stroke. The use echocardiography to characterize the risk of ischemic stroke in patients hospitalized with COVID-19 has not been explored. Methods We conducted a retrospective study of 368 patients hospitalized between 3/1/2020 and 5/31/2020 who had laboratory-confirmed infection with SARS-CoV-2 and underwent transthoracic echocardiography during hospitalization. Patients were categorized according to the presence of ischemic stroke on cerebrovascular imaging following echocardiography. Ischemic stroke was identified in 49 patients (13.3%). We characterized the risk of ischemic stroke using a novel composite risk score of clinical and echocardiographic variables: age <55, systolic blood pressure >140 mmHg, anticoagulation prior to admission, left atrial dilation and left ventricular thrombus. Results Patients with ischemic stroke had no difference in biomarkers of inflammation and hypercoagulability compared to those without ischemic stroke. Patients with ischemic stroke had significantly more left atrial dilation and left ventricular thrombus (48.3% vs 27.9%, p = 0.04; 4.2% vs 0.7%, p = 0.03). The unadjusted odds ratio of the composite novel COVID-19 Ischemic Stroke Risk Score for the likelihood of ischemic stroke was 4.1 (95% confidence interval 1.4-16.1). The AUC for the risk score was 0.70. Conclusions The COVID-19 Ischemic Stroke Risk Score utilizes clinical and echocardiographic parameters to robustly estimate the risk of ischemic stroke in patients hospitalized with COVID-19 and supports the use of echocardiography to characterize the risk of ischemic stroke in patients hospitalized with COVID-19.
Collapse
Affiliation(s)
- Connor P Oates
- Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
| | - Solomon W Bienstock
- The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Michael Miller
- Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Gennaro Giustino
- The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Tatyana Danilov
- Mount Sinai Beth Israel Hospital, New York, NY, United States
| | - Nina Kukar
- Mount Sinai St. Luke's and West Hospital, New York, NY, United States
| | - Nikola Kocovic
- Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Dylan Sperling
- Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Ranbir Singh
- Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Daniel Benhuri
- Mount Sinai Beth Israel Hospital, New York, NY, United States
| | - Frans Beerkens
- Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Anton Camaj
- The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Stamatios Lerakis
- The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Lori Croft
- The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Laura K Stein
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| | - Martin E Goldman
- The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
| |
Collapse
|
3
|
Affiliation(s)
- Abhinav Sood
- Department of Cardiovascular Medicine, Mount Sinai Beth Israel, New York, NY
| | - Daniel Benhuri
- Department of Cardiovascular Medicine, Mount Sinai Beth Israel, New York, NY
| | - Ujjwal Rastogi
- Department of Cardiovascular Medicine, Mount Sinai Beth Israel, New York, NY
| | - Ramesh M Gowda
- Department of Cardiovascular Medicine, Mount Sinai Beth Israel, New York, NY
| |
Collapse
|
4
|
Tholey RM, Abelson JS, Hassen S, Benhuri D, Zarnegar R, Dakin G, Pomp A, Afaneh C. Upper Gastrointestinal Studies After Laparoscopic Sleeve Gastrectomy: A Study that Prolongs Length of Stay. Bariatr Surg Pract Patient Care 2017. [DOI: 10.1089/bari.2016.0032] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Renee M. Tholey
- Department of Surgery, New York Presbyterian-Weill Cornell Medical College, New York, New York
| | - Jonathan S. Abelson
- Department of Surgery, New York Presbyterian-Weill Cornell Medical College, New York, New York
| | - Sara Hassen
- Department of Surgery, Weill Cornell Medical College-Qatar, Doha, Qatar
| | - Daniel Benhuri
- Department of Surgery, University of Toledo Medical Center, Toledo, Ohio
| | - Rasa Zarnegar
- Department of Surgery, New York Presbyterian-Weill Cornell Medical College, New York, New York
| | - Gregory Dakin
- Department of Surgery, New York Presbyterian-Weill Cornell Medical College, New York, New York
| | - Alfons Pomp
- Department of Surgery, New York Presbyterian-Weill Cornell Medical College, New York, New York
| | - Cheguevara Afaneh
- Department of Surgery, New York Presbyterian-Weill Cornell Medical College, New York, New York
| |
Collapse
|
5
|
Moore M, Afaneh C, Benhuri D, Antonacci C, Abelson J, Zarnegar R. Gastroesophageal reflux disease: A review of surgical decision making. World J Gastrointest Surg 2016; 8:77-83. [PMID: 26843915 PMCID: PMC4724590 DOI: 10.4240/wjgs.v8.i1.77] [Citation(s) in RCA: 52] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/30/2015] [Revised: 10/22/2015] [Accepted: 11/25/2015] [Indexed: 02/06/2023] Open
Abstract
Gastroesophageal reflux disease (GERD) is a very common disorder with increasing prevalence. It is estimated that up to 20%-25% of Americans experience symptoms of GERD weekly. Excessive reflux of acidic often with alkaline bile salt gastric and duodenal contents results in a multitude of symptoms for the patient including heartburn, regurgitation, cough, and dysphagia. There are also associated complications of GERD including erosive esophagitis, Barrett’s esophagus, stricture and adenocarcinoma of the esophagus. While first line treatments for GERD involve mainly lifestyle and non-surgical therapies, surgical interventions have proven to be effective in appropriate circumstances. Anti-reflux operations are aimed at creating an effective barrier to reflux at the gastroesophageal junction and thus attempt to improve physiologic and mechanical issues that may be involved in the pathogenesis of GERD. The decision for surgical intervention in the treatment of GERD, moreover, requires an objective confirmation of the diagnosis. Confirmation is achieved using various preoperative evaluations including: ambulatory pH monitoring, esophageal manometry, upper endoscopy (esophagogastroduodenoscopy) and barium swallow. Upon confirmation of the diagnosis and with appropriate patient criteria met, an anti-reflux operation is a good alternative to prolonged medical therapy. Currently, minimally invasive gastro-esophageal fundoplication is the gold standard for surgical intervention of GERD. Our review outlines the many factors that are involved in surgical decision-making. We will review the prominent features that reflect appropriate anti-reflux surgery and present suggestions that are pertinent to surgical practices, based on evidence-based studies.
Collapse
|